Treatment of Primary Menstrual Pain With Kanion Capsule

Jiangsu Kanion Pharmaceutical

Status and phase: Completed; Phase 2

Conditions: Primary Dysmenorrhea

Treatments: Drug: Kanion Capsule

Study type: Interventional

Funder types: Industry

Identifiers

NCT00523146

GF-2006-001

Details and patient eligibility

About

The objectives of this clinical trial are:

• To further study the safety of Kanion Capsule (GF) in primary dysmenorrhea subjects;
• To further evaluate the efficacy of GF in treatment of primary dysmenorrhea.

Sex: Female

Ages: 18 to 45 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• primary dysmenorrhea

Exclusion criteria

• secondary dysmenorrhea

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind